ArticleTranslational andrology and urology2026
Knowledge mapping of photodynamic therapy in bladder cancer: a bibliometric analysis (2000-2025).
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bladder cancer (BC) is the sixth most common cancer in men and one of the top 10 cancers in terms of the global cancer burden. Despite the rapid development and widespread application of photodynamic therapy (PDT) in BC research, a comprehensive analysis and bibliometric evaluation of the development trends in this field have yet to be conducted. This study aims to quantify and visualize the research output, major contributors, intellectual structure, and emerging frontiers in photodynamic therapy for bladder cancer research from 2000 to 2025. Methods: Articles on PDT in BC published from 2000 to 2025 were retrieved from the Web of Science Core Collection (WoSCC) database. A bibliometric analysis was performed using VOSviewer, CiteSpace, Python, and the R package "bibliometrix". Results: A total of 595 articles from 42 countries were included in the analysis, of which the majority originated from China and the United States. The number of publications related to PDT in BC continues to increase annually. The National University of Singapore, the University of Leuven, the German National Cancer Center, and the University of Coimbra in Portugal were the main research institutions with the highest publication volumes. Conclusions: A bibliometric analysis was conducted to examine research on PDT in BC from 2000 to 2025. The investigation identified key trends, collaborative networks, and central research themes, including the application of hypericin and the integration of immunotherapy. While China and the United States were the leading contributors in terms of publication output, international collaborative efforts remained relatively limited. The findings underscore a notable evolution in the field, characterized by a focus on photosensitizer optimization and the development of novel therapeutic strategies. Emerging research directions notably include advancements in nanotechnology, immunotherapeutic approaches, and combination treatment regimens. In summary, this analysis provides a comprehensive mapping of the current knowledge landscape, offering valuable insights to guide future research initiatives in this domain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.